Forecast & Rating2 analysts currently cover HAIXI PHARMA, of which 2 give a positive rating. The average price target is HK$290.49, about 46.3% upside from the current price of HK$198.60. Coverage is limited, so the data is for reference only. Data as of Jun 13, 2026; this does not constitute investment advice.
Jun 10, 2026Price forecast
HK$290.4946.27%
Forecast & RatingStrong buy
2analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 26, 2026
Forecast met3.5%
Stock price$198.60
Avg. target$290.5
High target$301
Low target$280
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.